BLUTSTILLENDE VORRICHTUNG

European patent · EP4241708 · In force

Register entry

Publication number
EP4241708
Application number
EP22305267
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 9, 2022
Published
Sep 13, 2023
Granted
Aug 19, 2026
Protection ends at the latest
Mar 8, 2042
Next annual fee due
Mar 31, 2027
IPC classes
A61B 17/42 (2006.01)
A61B 17/12 (2006.01)
A61B 17/30 (2006.01)
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 19, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.08.2026

Parties

Holder

Matria Health Technologies

75 avenue Gabriel Péri, 38400 Saint Martin d'Heres, FR

Inventor

URVOY, François

38330 SAINT-NAZAIRE-LES-EYMES, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.